Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cepok

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[New approaches in research of therapy of multiple sclerosis]B Hemmer, S Cepok, S Nessler, et al.
American Journal of Primatology|September 8, 1998
Sex-specific usage patterns of sleeping sites in grey mouse lemurs (Microcebus murinus) in northwestern MadagascarU Radespiel, S Cepok, V Zietemann, et al.
Journal of Neurobiology|May 3, 2001
Digger wasp versus cricket: mechanisms underlying the total paralysis caused by the predator's venomM Ferber, M Hörner, S Cepok, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 24, 2001
New approaches to dissect degeneracy and specificity in T cell antigen recognitionM Jacobsen, S Cepok, W H Oertel, et al.
Brain Research|March 5, 1999
NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptorsI Nijholt, T Blank, B Grafelmann, et al.
Neurology|April 23, 2010
Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseasesR C Selter, F Brilot, V Grummel, et al.
Brain : a Journal of Neurology|October 24, 2001
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosisS Cepok, M Jacobsen, S Schock, et al.
Neurology|April 6, 2011
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MSM C Kowarik, H L Pellkofer, S Cepok, et al.
The Pharmacogenomics Journal|April 20, 2011
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patientsF Weber, S Cepok, C Wolf, et al.
Journal of Neuroimmunology|September 11, 2007
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesionsM Krumbholz, D Theil, F Steinmeyer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[New approaches in research of therapy of multiple sclerosis]B Hemmer, S Cepok, S Nessler, et al.
American Journal of Primatology|September 8, 1998
Sex-specific usage patterns of sleeping sites in grey mouse lemurs (Microcebus murinus) in northwestern MadagascarU Radespiel, S Cepok, V Zietemann, et al.
Journal of Neurobiology|May 3, 2001
Digger wasp versus cricket: mechanisms underlying the total paralysis caused by the predator's venomM Ferber, M Hörner, S Cepok, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 24, 2001
New approaches to dissect degeneracy and specificity in T cell antigen recognitionM Jacobsen, S Cepok, W H Oertel, et al.
Brain Research|March 5, 1999
NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptorsI Nijholt, T Blank, B Grafelmann, et al.
Neurology|April 23, 2010
Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseasesR C Selter, F Brilot, V Grummel, et al.
Brain : a Journal of Neurology|October 24, 2001
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosisS Cepok, M Jacobsen, S Schock, et al.
Neurology|April 6, 2011
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MSM C Kowarik, H L Pellkofer, S Cepok, et al.
The Pharmacogenomics Journal|April 20, 2011
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patientsF Weber, S Cepok, C Wolf, et al.
Journal of Neuroimmunology|September 11, 2007
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesionsM Krumbholz, D Theil, F Steinmeyer, et al.
Pageof 2